HIV Funding Impacts Global health funding · LMIC Download the panel

Home  /  Middle East and North Africa  /  DZA

Algeria

Algeria appears only through international and donor bodies that compile figures across many countries, and no figures for the country are read directly from a national publisher. The assessment of national sources, country by country, is set out on the Methods page.

29,000
People living with HIV, 2025
WHO Global Health Observatory
80.0%
On antiretroviral treatment, 2025
WHO Global Health Observatory
$22k
United States HIV disbursements, 2013
OECD Creditor Reporting System
$105k
External HIV financing, all donors, 2024
OECD Creditor Reporting System
External HIV financing
OECD CRS · ForeignAssistance.gov
$0$1m$2m20022005200820112014201720202023$105k$22k$6k$22k
  • All donors
  • United States, OECD record
  • The Global Fund
  • United States, self-reported
YearAll donorsUnited States, OECD recordThe Global FundUnited States, self-reported
2002 $53k — — —
2003 $3k — — —
2004 $1.6m — $1.6m —
2005 $1.1m — $1.0m —
2006 $2.2m — $1.9m —
2007 $1.7m — $400k —
2008 $2.5m — $2.1m —
2009 $1.2m $8k — $8k
2010 $1.1m $66k — $66k
2011 $1.0m — — —
2012 $310k — — —
2013 $310k $22k — $22k
2014 $123k — — —
2015 $278k — — —
2016 $240k — — —
2017 $1.2m — $638k —
2018 $2.4m — $2.2m —
2019 $2.6m — $2.5m —
2020 $634k — $575k —
2021 $1.7m — $1.7m —
2022 $953k — $848k —
2023 $681k — $570k —
2024 $105k — $6k —

23 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Disbursements reported for the country. The OECD record and the United States self-reported record are drawn separately. The two records cover the same United States disbursements, but the OECD record is filed by calendar year and the self-reported record by United States fiscal year.

People living with HIV and people on treatment
UNAIDS AIDSinfo
010k20k30k20002003200620092012201520182021202430,00020,000
  • People living with HIV
  • People on treatment
YearPeople living with HIVPeople living with HIV (lower)People living with HIV (upper)People on treatment
2000 2,600 2,400 2,700 —
2001 3,000 2,900 3,200 —
2002 3,600 3,400 3,700 —
2003 4,200 4,000 4,400 —
2004 4,900 4,600 5,100 —
2005 5,700 5,400 6,000 —
2006 6,600 6,200 7,000 —
2007 7,600 7,200 8,100 —
2008 8,700 8,100 9,200 —
2009 9,700 9,000 10,000 —
2010 11,000 9,900 11,000 2,200
2011 11,000 11,000 12,000 2,700
2012 12,000 12,000 13,000 3,400
2013 13,000 12,000 14,000 4,600
2014 14,000 13,000 15,000 6,000
2015 15,000 14,000 16,000 7,700
2016 16,000 15,000 17,000 9,600
2017 17,000 16,000 18,000 11,000
2018 19,000 17,000 20,000 13,000
2019 20,000 18,000 22,000 14,000
2020 22,000 20,000 24,000 16,000
2021 23,000 21,000 26,000 17,000
2022 25,000 23,000 28,000 18,000
2023 28,000 25,000 31,000 20,000
2024 30,000 26,000 34,000 20,000

25 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Modelled estimates. The shaded area is the published uncertainty interval around the number of people living with HIV, because a single estimate without the interval would overstate the precision of the model.

The treatment cascade
UNAIDS AIDSinfo
0%25%50%75%2010201220142016201820202022202486.0%68.0%65.0%
  • Diagnosed
  • On treatment
  • Virally suppressed
YearDiagnosedOn treatmentVirally suppressed
2010 38.0% 21.0% —
2011 40.0% 23.0% —
2012 44.0% 28.0% 24.0%
2013 51.0% 35.0% 31.0%
2014 57.0% 43.0% 37.0%
2015 66.0% 51.0% 45.0%
2016 75.0% 59.0% 52.0%
2017 80.0% 64.0% 56.0%
2018 84.0% 69.0% 60.0%
2019 86.0% 72.0% 65.0%
2020 87.0% 72.0% —
2021 88.0% 74.0% —
2022 86.0% 69.0% —
2023 87.0% 71.0% —
2024 86.0% 68.0% —

15 rows, as drawn above. Values are rounded for display, and the download gives the unrounded values.

Every line is a percentage of all people living with HIV, so the three lines share a denominator and can be compared directly. Viral suppression in the figure is the share of all people living with HIV who are virally suppressed, and not the narrower third 95 target, which counts only people on treatment.

Sources of the figures for Algeria

2,572 rows

SourceTypeRowsIndicators YearsRead fromRetrieved
UNICEF HIV/AIDS dataset Modelled estimate 1,376 5 2010–2025 sdmx.data.unicef.org 2026-10-20
UNAIDS AIDSinfo Modelled estimate 736 25 2000–2024 aidsinfo.unaids.org 2026-10-20
WHO Global Health Observatory Modelled estimate 215 12 2000–2025 ghoapi.azureedge.net 2026-10-12
WHO Global Tuberculosis Programme Programme record 64 7 2000–2024 extranet.who.int 2026-10-16
World Bank Open Data Modelled estimate 51 2 2000–2025 api.worldbank.org 2026-10-12
OECD Creditor Reporting System Expenditure account 39 3 2002–2024 sdmx.oecd.org 2026-10-12
IATI, through d-portal Expenditure account 38 3 2004–2026 d-portal.org 2026-10-12
Global Fund Data Service Programme record 17 3 2017–2025 fetch.theglobalfund.org 2026-10-12
UNAIDS Global AIDS Monitoring expenditure database Expenditure account 16 16 2017 hivfinancial.unaids.org 2026-10-12
WHO HIV testing services dashboard Programme record 10 3 2018–2024 eic-database-290813.ew.r.appspot.com 2026-10-14
ForeignAssistance.gov Expenditure account 6 2 2009–2013 foreignassistance.gov 2026-10-29
UNAIDS Data 2025 country databook Expenditure account 3 3 2017 aidsinfo.unaids.org 2026-10-15
Global Fund allocations Expenditure account 1 1 2017 fetch.theglobalfund.org 2026-10-12

Indicators held

55 of 150

IndicatorDomainUnitRows YearsSourcesMost recent value
Country-reported HIV expenditure, all sources Financing USD 5 2012–2017 UNAIDS AIDSinfo, UNAIDS Global AIDS Monitoring expenditure database $31.9m (2017)
Domestic funding received by the national TB programme Financing USD 1 2017 WHO Global Tuberculosis Programme $811k (2017)
Domestic public HIV expenditure Financing USD 2 2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $25.4m (2017)
External HIV financing (all donors, ODA) Financing USD 23 2002–2024 OECD Creditor Reporting System $105k (2024)
External HIV financing from governments other than the United States (IATI) Financing USD 9 2007–2024 IATI, through d-portal $399k (2024)
External HIV financing from multilateral bodies other than the Global Fund (IATI) Financing USD 15 2012–2026 IATI, through d-portal $3k (2026)
External HIV financing from the United States (ODA) Financing USD 6 2009–2013 ForeignAssistance.gov, OECD Creditor Reporting System $22k (2013)
Global Fund HIV allocation for a whole three-year cycle, not an annual figure Financing USD per three-year allocation cycle 1 2017 Global Fund allocations 2,312,936 (2017)
Global Fund HIV disbursements to the country Financing USD 28 2004–2025 IATI, through d-portal, OECD Creditor Reporting System, UNAIDS Global AIDS Monitoring expenditure database $10k (2025)
HIV spending on TB/HIV co-infection Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $34k (2017)
HIV spending on community mobilisation and system strengthening Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $153k (2017)
HIV spending on critical enablers Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $63k (2017)
HIV spending on gender programmes Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $18k (2017)
HIV spending on governance and sustainability Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $879k (2017)
HIV spending on prevention Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $1.0m (2017)
HIV spending on prevention of vertical transmission Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $4.8m (2017)
HIV spending on programmes for children and adolescents Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $99k (2017)
HIV spending on social protection and economic support Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $279k (2017)
HIV spending on treatment, care and support Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $24.5m (2017)
International HIV expenditure (country-reported) Financing USD 2 2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $573k (2017)
Other bilateral HIV expenditure (country-reported) Financing USD 1 2017 UNAIDS Global AIDS Monitoring expenditure database $54k (2017)
Private HIV expenditure (country-reported) Financing USD 2 2017 UNAIDS Data 2025 country databook, UNAIDS Global AIDS Monitoring expenditure database $6.0m (2017)
US HIV disbursements managed by other US agencies Financing USD 3 2009–2013 ForeignAssistance.gov $22k (2013)
% of ALL PLHIV who are virally suppressed Treatment cascade percent 14 2012–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 78.0% (2025)
% of PLHIV on ART (second 95, PLHIV base) Treatment cascade percent 55 2000–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 80.0% (2025)
% of PLHIV who have been diagnosed (first 95) Treatment cascade percent 29 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 94.0% (2025)
% of estimated HIV-positive incident TB cases on TB treatment and ART Treatment cascade percent 3 2019–2024 UNAIDS AIDSinfo 0.1% (2024)
% of people newly enrolled in HIV treatment diagnosed with TB disease Treatment cascade percent 5 2015–2024 UNAIDS AIDSinfo 12.3% (2024)
% of people on ART who are virally suppressed (third 95) Treatment cascade percent 6 2015–2025 WHO Global Health Observatory 97.0% (2025)
% of returned HIV test results that were positive Treatment cascade percent 6 2018–2024 UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 0.3% (2024)
HIV tests performed at a health facility Treatment cascade count 2 2018–2024 WHO HIV testing services dashboard 871,490 (2024)
HIV tests performed with the result returned to the person Treatment cascade count 8 2018–2024 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory, WHO HIV testing services dashboard 871,490 (2024)
HIV-exposed infants tested within two months of birth Treatment cascade percent 10 2011–2024 UNAIDS AIDSinfo 21.0% (2024)
HIV-positive TB patients started or continued on ART Treatment cascade count 3 2019–2024 WHO Global Tuberculosis Programme 0 (2024)
Key-population people tested for HIV (count over the period) Treatment cascade count 7 2018–2025 Global Fund Data Service By population group, sex or age only, to 2025
New HIV diagnoses with a CD4 count below 200 Treatment cascade percent 4 2015–2018 UNAIDS AIDSinfo 17.0% (2018)
Number of people on ART (PEPFAR MER TX_CURR) Treatment cascade count 63 2000–2025 Global Fund Data Service, UNAIDS AIDSinfo, WHO Global Health Observatory 23,333 (2025)
PMTCT ART coverage among pregnant women with HIV Treatment cascade percent 26 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 73.0% (2025)
People newly enrolled on ART during the year Treatment cascade count 5 2015–2024 WHO Global Tuberculosis Programme 2,474 (2024)
Pregnant women tested for HIV in antenatal care Treatment cascade percent 4 2015–2020 UNAIDS AIDSinfo 6.0% (2020)
Pregnant women with HIV who received ARVs for PMTCT Treatment cascade count 26 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 307 (2025)
TB patients recorded as HIV-positive Treatment cascade count 3 2019–2024 WHO Global Tuberculosis Programme 0 (2024)
TB patients with an HIV test result recorded Treatment cascade count 2 2022–2024 WHO Global Tuberculosis Programme 0 (2024)
AIDS-related deaths Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 500 (2025)
Deaths from TB among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 56 (2024)
HIV prevalence among a key population Epidemic estimates percent 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
HIV prevalence, ages 15-49 Epidemic estimates percent 50 2000–2024 UNAIDS AIDSinfo, World Bank Open Data 0.1% (2024)
Incident TB cases among people living with HIV Epidemic estimates count 50 2000–2024 UNAIDS AIDSinfo, WHO Global Tuberculosis Programme 210 (2024)
New HIV infections Epidemic estimates count 585 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 2,700 (2025)
People living with HIV Epidemic estimates count 681 2000–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset, WHO Global Health Observatory 29,000 (2025)
Key-population members reached by prevention programmes Prevention and outreach percent 2 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Estimated pregnant women with HIV needing ARVs for PMTCT Population denominators count 26 2010–2025 UNAIDS AIDSinfo, WHO Global Health Observatory 500 (2025)
Estimated size of a key population Population denominators count 3 2024 UNAIDS AIDSinfo By population group, sex or age only, to 2024
Total population Population denominators count 26 2000–2025 World Bank Open Data 47,435,312 (2025)
Share of HIV-exposed infants who acquire HIV — percent 26 2010–2025 UNAIDS AIDSinfo, UNICEF HIV/AIDS dataset 24.6% (2025)

Every row shown on the Algeria page is in the panel download, with the source URL and the retrieval date of the row attached. See Data.